Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Other Non-Current Assets (2016 - 2025)

Sanofi (SNY) has disclosed Other Non-Current Assets for 11 consecutive years, with $5.1 billion as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 26.67% to $5.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 billion through Dec 2025, up 26.67% year-over-year, with the annual reading at $4.9 billion for FY2025, 21.38% up from the prior year.
  • Other Non-Current Assets hit $5.1 billion in Q4 2025 for Sanofi, up from $4.0 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $5.1 billion in Q4 2025 to a low of $3.2 billion in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $3.9 billion across 5 years, with a median of $3.6 billion in 2021.
  • Biggest five-year swings in Other Non-Current Assets: dropped 11.73% in 2022 and later rose 26.67% in 2025.
  • Year by year, Other Non-Current Assets stood at $3.6 billion in 2021, then fell by 11.73% to $3.2 billion in 2022, then rose by 9.65% to $3.5 billion in 2023, then grew by 15.83% to $4.0 billion in 2024, then grew by 26.67% to $5.1 billion in 2025.
  • Business Quant data shows Other Non-Current Assets for SNY at $5.1 billion in Q4 2025, $4.0 billion in Q4 2024, and $3.5 billion in Q4 2023.